Source: FinanzNachrichten

LifeScan: Lifescan, Inc.: Study Results Published in Diabetes Technology and Therapeutics Show Clinically Significant Improved Glycemic Control in People with Diabetes Using a Smart Blood Glucose Meter and Mobile App

MALVERN, Pa., Nov. 7, 2022 /PRNewswire/ -- LifeScan, a world leader in blood glucose monitoring, today announced that the peer-reviewed journal Diabetes Technology and Therapeutics (DTT) has publi...

Read full article »
Est. Annual Revenue
$1.0-5.0B
Est. Employees
1.0-5.0K
Valerie Asbury's photo - President & CEO of LifeScan

President & CEO

Valerie Asbury

CEO Approval Rating

65/100

Read more